Cell Manipulation Core Facility at Dana-Farber Cancer Institute
The Connell and O’Reilly Families Cell Manipulation Core Facility (CMCF) at Dana-Farber Cancer Institute is a state-of-the-art academic GMP laboratory dedica…
Related Articles
NX-5948 Earns Fast Track Designation in R/R Waldenström Macroglobulinemia
Results from a phase 1a trial showed that NX-5948 yielded an overall response rate of 77.8% in later lines of treatment for patients with WM.
#ASH24: Late-phase trials and real-world studies in AML
Catch up with our live social media coverage of late-phase trials and real-world studies in AML from the 66th ASH Annual Meeting and Exposition, December…
The Value of New Fluid Management Technologies for Heart Failure
Heart failure is associated with a very high hospital readmission rate, which is burdensome and costly for patients, hospitals, and healthcare systems. Earli…
Project documents | Pembrolizumab for adjuvant treatment of resected non-small-cell lung cancer [ID3907] | Guidance | NICE
Pembrolizumab for adjuvant treatment of resected non-small-cell lung cancer [ID3907]
AACR-Johnson & Johnson Interventional Oncology Stimulating Therapeutic Advances through Research Training (START) Grants
Three-year grant of $225,000 to support the salary and benefits of postdoctoral or clinical research fellows conducting lung cancer research.
ELCIN: elacestrant in CDK4/6 inhibitor-naïve ER+/HER2- metastatic breast cancer
Virginia Kaklamani, MD, UT Health San Antonio, San Antonio, TX, discusses the rationale and design of the Phase II ELCIN trial (NCT05596409) of elacestrant in…
ASTROblog – American Society for Radiation Oncology (ASTRO)
The ASTROblog covers current topics in radiation oncology. Posts are authored by ASTRO members and staff. If you have a topic idea for a blog, email…
CD News | American Association for Cancer Research
The cereblon E3 ligase modulator cemsidomide showed activity against multiple myeloma and two types of non–Hodgkin lymphoma in a phase I study. The U.S. government…
Radiation Myelitis After Hypofractionated Spine Stereotactic Body Radiation Therapy
This cohort study characterizes the risk of radiation myelitis after spine stereotactic body radiation therapy to update the current dosimetric constraints.
Jalajabandhu🪷🌊| Alarshara Paritaapam🏹| Raga Surutti|Swati Tirunal Composition|Saraswati Veena
Watch the full video: https://youtu.be/kkdcIKTWSb0?si=sm-pCV4qU-_Gy6x7 Check out the lyrics and meaning here: https://www.swathithirunalfestival.org/composit…
